Azenta (AZTA) Set to Announce Quarterly Earnings on Tuesday

Azenta (NASDAQ:AZTA) is scheduled to release its earnings data after the market closes on Tuesday, November 12th. Analysts expect Azenta to post earnings of $0.11 per share for the quarter.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.09. The firm had revenue of $173.00 million for the quarter, compared to analyst estimates of $166.14 million. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. The business’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.13 EPS. On average, analysts expect Azenta to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Azenta Stock Performance

Shares of NASDAQ:AZTA traded up $1.11 during midday trading on Tuesday, reaching $46.01. 399,524 shares of the company’s stock were exchanged, compared to its average volume of 493,516. The firm has a market capitalization of $2.25 billion, a PE ratio of -16.01 and a beta of 1.48. The company’s 50 day simple moving average is $46.22 and its two-hundred day simple moving average is $50.88. Azenta has a 12 month low of $40.24 and a 12 month high of $69.16.

Insider Transactions at Azenta

In related news, CFO Herman Cueto sold 1,595 shares of the firm’s stock in a transaction on Thursday, October 17th. The stock was sold at an average price of $43.68, for a total transaction of $69,669.60. Following the completion of the sale, the chief financial officer now directly owns 24,604 shares of the company’s stock, valued at $1,074,702.72. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.77% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on AZTA shares. Evercore ISI lowered their price objective on Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Needham & Company LLC reiterated a “buy” rating and set a $69.00 price objective on shares of Azenta in a research note on Wednesday, August 7th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $66.40.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.